Latest news:
FDA Announces Shift Away from Mandatory Animal Testing – BioReperia Offers a Validated, Human-Relevant Alternative
Read more
/

On-demand webinar

A New Translational In Vivo Tool for Oncology Drug Discovery: Zebrafish Tumor Xenograft Model

Join us in an on-demand Webinar hosted by Charles River laboratories as we explore the zebrafish platform and how it complements mouse PDX approaches.

You will access the webinar through Charles River´s homepage by klicking on the button below.

Webinar presenters

Julia Schüler, DVM, PhD

Research Director at Charles River Laboratories


Anna Erkstam, PhD

Chief Operating Officer at BioReperia AB


Lasse Jensen, PhD

Chief Executive Officer, BioReperia AB